Scarica l'app Stockscreener
1.41
3.42%
-0.05
Dopo l'orario di chiusura:
1.42
0.01
+0.71%
Precedente Chiudi:
$1.46
Aprire:
$1.49
Volume 24 ore:
32,547
Relative Volume:
0.18
Capitalizzazione di mercato:
$7.73M
Reddito:
-
Utile/perdita netta:
$-6.91M
Rapporto P/E:
-0.4325
EPS:
-3.26
Flusso di cassa netto:
$-6.14M
1 W Prestazione:
-9.32%
1M Prestazione:
-4.73%
6M Prestazione:
+3.68%
1 anno Prestazione:
-61.26%
Intervallo 1D:
$1.40
$1.49
Intervallo di 1 settimana:
$1.3701
$1.5999
Portata 52W:
$1.15
$4.81
Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile
Nome
Galmed Pharmaceuticals Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta GLMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GLMD
Galmed Pharmaceuticals Ltd
|
1.41 | 7.89M | 0 | -6.91M | -6.14M | -3.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-05-22 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2020-02-04 | Iniziato | Craig Hallum | Buy |
| 2020-01-30 | Ripresa | Cantor Fitzgerald | Overweight |
| 2019-12-02 | Iniziato | Canaccord Genuity | Buy |
| 2018-12-12 | Iniziato | B. Riley FBR | Buy |
| 2018-08-02 | Reiterato | Maxim Group | Buy |
| 2018-07-13 | Iniziato | Stifel | Buy |
| 2018-07-12 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-06-12 | Reiterato | H.C. Wainwright | Buy |
| 2018-03-15 | Aggiornamento | Maxim Group | Hold → Buy |
| 2018-02-14 | Downgrade | Maxim Group | Buy → Hold |
| 2018-02-12 | Reiterato | H.C. Wainwright | Buy |
| 2017-11-15 | Iniziato | ROTH Capital | Buy |
| 2017-08-08 | Reiterato | H.C. Wainwright | Buy |
| 2017-07-31 | Reiterato | Maxim Group | Buy |
| 2016-08-01 | Reiterato | Maxim Group | Buy |
| 2016-07-06 | Ripresa | ROTH Capital | Buy |
| 2016-03-28 | Ripresa | H.C. Wainwright | Buy |
| 2015-06-23 | Iniziato | H.C. Wainwright | Buy |
| 2015-05-06 | Iniziato | Sun Trust Rbsn Humphrey | Buy |
Mostra tutto
Galmed Pharmaceuticals Ltd Borsa (GLMD) Ultime notizie
Applying Elliott Wave Theory to Galmed Pharmaceuticals Ltd.2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com
How to monitor Galmed Pharmaceuticals Ltd. with trend dashboardsJuly 2025 Decliners & Fast Gaining Stock Strategy Reports - newser.com
Understanding Galmed Pharmaceuticals Ltd.’s price movementWeekly Loss Report & Weekly Sector Rotation Insights - newser.com
Can you recover from losses in Galmed Pharmaceuticals Ltd.Dip Buying & Long-Term Safe Investment Ideas - newser.com
Is Galmed Pharmaceuticals Ltd. a candidate for recovery playJuly 2025 Catalysts & High Accuracy Swing Trade Signals - newser.com
How Galmed Pharmaceuticals Ltd. stock reacts to inflationary pressuresJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - newser.com
What to do if you’re stuck in Galmed Pharmaceuticals Ltd.July 2025 Sector Moves & Safe Swing Trade Setups - newser.com
Can volume confirm reversal in Galmed Pharmaceuticals Ltd.Portfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com
What data driven models say about Galmed Pharmaceuticals Ltd.’s futureIPO Watch & Verified Entry Point Detection - newser.com
Will Galmed Pharmaceuticals Ltd. benefit from macro trendsJuly 2025 Catalysts & Safe Capital Investment Plans - newser.com
Why Galmed Pharmaceuticals Ltd. stock remains on buy listsProfit Target & AI Powered Market Entry Strategies - newser.com
What institutional flow reveals about Galmed Pharmaceuticals Ltd.2025 Price Targets & Community Consensus Picks - newser.com
Building trade automation scripts for Galmed Pharmaceuticals Ltd.July 2025 Patterns & Community Consensus Trade Alerts - newser.com
Is Galmed Pharmaceuticals Ltd. stock a top momentum playJuly 2025 Fed Impact & High Yield Stock Recommendations - newser.com
Galmed Pharmaceuticals Ltd.’s volatility index tracking explainedWeekly Trade Summary & Community Consensus Trade Signals - newser.com
What drives Galmed Pharmaceuticals Ltd stock priceMid Cap Growth Trends & Investment Portfolio Recommendations - earlytimes.in
How Galmed Pharmaceuticals Ltd. stock reacts to Fed rate cuts2025 Market Trends & Community Consensus Stock Picks - newser.com
Weiss Ratings Reiterates “Sell (E+)” Rating for Galmed Pharmaceuticals (NASDAQ:GLMD) - Defense World
News impact scoring models applied to Galmed Pharmaceuticals Ltd.Weekly Trading Summary & Verified Momentum Stock Watchlist - newser.com
Will Galmed Pharmaceuticals Ltd. (GPH) stock outperform benchmarksShort Setup & Advanced Technical Analysis Signals - newser.com
What the charts say about Galmed Pharmaceuticals Ltd. todayQuarterly Trade Review & Breakout Confirmation Trade Signals - newser.com
Galmed Pharmaceuticals Ltd. stock prediction for this weekJuly 2025 Breakouts & Reliable Trade Execution Plans - newser.com
Combining machine learning predictions for Galmed Pharmaceuticals Ltd.July 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - newser.com
Published on: 2025-10-03 05:59:14 - newser.com
Can Galmed Pharmaceuticals Ltd. (GPH) stock withstand sector downturnsSwing Trade & Verified Chart Pattern Trade Signals - newser.com
Galmed Pharmaceuticals Ltd Azioni (GLMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):